Get the tools used by (smart)2 investors.

EV / Free Cash Flow for Johnson & Johnson

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

JNJ: Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, In...

163.24 USD
Price
USD
Fair Value
Upside
140.68 - 169.99
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Johnson & Johnson's EV / Free Cash Flow:

Dec 2016Dec 2018Dec 2020Dec 2022Dec 202415.0x20.0x25.0x

Performance Summary
  • Johnson & Johnson's latest twelve months ev / free cash flow is 17.3x
  • Johnson & Johnson's ev / free cash flow for fiscal years ending January 2021 to 2024 averaged 17.9x.
  • Johnson & Johnson's operated at median ev / free cash flow of 17.3x from fiscal years ending January 2021 to 2024.
  • Looking back at the last 5 years, Johnson & Johnson's ev / free cash flow peaked in January 2023 at 22.1x.
  • Johnson & Johnson's ev / free cash flow hit its 5-year low in January 2022 of 14.9x.
  • Johnson & Johnson's ev / free cash flow decreased in 2022 (14.9x, -21.2%) and 2023 (16.1x, -27.2%) and increased in 2021 (18.9x, +45.0%), 2023 (22.1x, +48.3%), and 2024 (17.3x, +7.6%).

Benchmarks

Metric Usage: EV / Free Cash Flow

Hide this widget
ev_to_fcf_ltm
Slug
number
Datatype
text
Format
current
Default Period
FY, LTM
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to EV / Free Cash Flow in the valuation category include:

View Full List

Search for metric or datapoint

EV / Free Cash Flow

Measures the dollars in Enterprise Value for each dollar of free cash flow over the last twelve months.

Definition of EV / Free Cash Flow

Hide this widget

Enterprise Value / Free Cash Flow measures the dollars in Enterprise Value for each dollar of unlevered free cash flow earned over the last 12 months.

TEV / UFCF = Total Enterprise Value / Unlevered Free Cash Flow

Applying this formula, Johnson & Johnson’s EV/FCF is calculated below:

Total Enterprise Value [ $407.6 B ]
(/) Unlevered Free Cash Flow [ $23.508 B ]
(=) TEV / UFCF [ 17.3x ]

The tables below summarizes the trend in Johnson & Johnson’s EV/FCF over the last five years:

Date Enterprise Value Unlevered Free Cash Flow TEV / UFCF
2021-01-03 $493.8 B $26.062 B 18.9
2022-01-02 $302.2 B $20.246 B 14.9
2023-01-01 $437.8 B $19.783 B 22.1
2023-12-31 $415.6 B $25.79 B 16.1
2024-12-29 $407.6 B $23.508 B 17.3

Read more about total enterprise value (tev) and unlevered free cash flow


Click the link below to download a spreadsheet with an example EV / Free Cash Flow calculation for Johnson & Johnson below:

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-118.8x-58.8x1.2x113.9x0200400600

The chart above depicts the distribution of ev / free cash flow for companies operating in the Healthcare sector in the Developed economic region. Over 2,190 companies were considered in this analysis, and 2,111 had meaningful values. The average ev / free cash flow of companies in the sector is -0.6x with a standard deviation of 26.7x.

Johnson & Johnson's EV / Free Cash Flow of 17.3x ranks in the 84.2% percentile for the sector. The following table provides additional summary stats:

EV / Free Cash Flow In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents2,199
Included Constituents2,111
Min-122.2x
Max109.7x
Median-1.7x
Mean-0.6x
Standard Deviation26.7x

You can find companies with similar ev / free cash flow using this stock screener.

All rights reserved. Terms Of Use